You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

AVANDARYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Avandaryl, and what generic alternatives are available?

Avandaryl is a drug marketed by Sb Pharmco and is included in one NDA.

The generic ingredient in AVANDARYL is glimepiride; rosiglitazone maleate. There are sixteen drug master file entries for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.

Drug patent expirations by year for AVANDARYL
Recent Clinical Trials for AVANDARYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 3

See all AVANDARYL clinical trials

Paragraph IV (Patent) Challenges for AVANDARYL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AVANDARYL Tablets glimepiride; rosiglitazone maleate 8 mg/2 mg 8 mg/4 mg 021700 1 2008-05-30
AVANDARYL Tablets glimepiride; rosiglitazone maleate 1 mg/4 mg 2 mg/4 mg 4 mg/4 mg 021700 1 2006-12-22

US Patents and Regulatory Information for AVANDARYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sb Pharmco AVANDARYL glimepiride; rosiglitazone maleate TABLET;ORAL 021700-001 Nov 23, 2005 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sb Pharmco AVANDARYL glimepiride; rosiglitazone maleate TABLET;ORAL 021700-003 Nov 23, 2005 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sb Pharmco AVANDARYL glimepiride; rosiglitazone maleate TABLET;ORAL 021700-002 Nov 23, 2005 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sb Pharmco AVANDARYL glimepiride; rosiglitazone maleate TABLET;ORAL 021700-004 Mar 30, 2007 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sb Pharmco AVANDARYL glimepiride; rosiglitazone maleate TABLET;ORAL 021700-005 Mar 30, 2007 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AVANDARYL

International Patents for AVANDARYL

See the table below for patents covering AVANDARYL around the world.

Country Patent Number Title Estimated Expiration
Denmark 490288 ⤷  Try a Trial
Japan H10194970 ANTIHYPERLIPIDEMIC MEDICINE CONTAINING SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVE ⤷  Try a Trial
Spain 2137915 ⤷  Try a Trial
Hungary 0200937 ⤷  Try a Trial
Israel 106904 PYRIDYLAMINO- ETHOXYBENZYL- THIAZOLIDINE-2, 4-DIONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Try a Trial
Argentina 023750 UN PROCESO PARA PREPARAR UNA FORMA POLIMORFICA DE LA SAL DEL ACIDO MALEICO DERIVADO DE LA TIAZOLIDINA-2,4-DIONA ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for AVANDARYL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0306228 C300034 Netherlands ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT, IN HET BIJZONDER ROSIGLITAZONE MALEAAT; REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711
0658161 CA 2001 00001 Denmark ⤷  Try a Trial
0306228 2001C/004 Belgium ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE; REGISTRATION NO/DATE: EU/1/00/137/001 20000717
0658161 39/2000 Austria ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
0306228 38/2000 Austria ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
0658161 C300035 Netherlands ⤷  Try a Trial PRODUCT: ROSIGLITAZONE,MALEAAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT.
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.